Tandem Diabetes Care, Inc. (TNDM)
NASDAQ: TNDM · IEX Real-Time Price · USD
34.97
+3.24 (10.21%)
Apr 23, 2024, 4:00 PM EDT - Market closed
Tandem Diabetes Care Stock Forecast
Stock Price Forecast
The 12 analysts with 12-month price forecasts for TNDM stock have an average target of 36.17, with a low estimate of 21 and a high estimate of 62. The average target predicts an increase of 3.43% from the current stock price of 34.97.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TNDM stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 7 | 7 | 7 | 7 | 7 | 5 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 14 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Stifel | Stifel | Strong Buy Maintains $37 → $40 | Strong Buy | Maintains | $37 → $40 | +14.38% | Apr 23, 2024 |
| Citigroup | Citigroup | Hold Maintains $31 → $38 | Hold | Maintains | $31 → $38 | +8.66% | Apr 3, 2024 |
| Stifel | Stifel | Hold → Strong Buy Upgrades n/a | Hold → Strong Buy | Upgrades | n/a | n/a | Mar 26, 2024 |
| Citigroup | Citigroup | Hold Maintains $25 → $31 | Hold | Maintains | $25 → $31 | -11.35% | Mar 15, 2024 |
| Stifel | Stifel | Hold Maintains $17 → $24 | Hold | Maintains | $17 → $24 | -31.37% | Feb 5, 2024 |
Financial Forecast
Revenue This Year
862.22M
from 747.72M
Increased by 15.31%
Revenue Next Year
961.43M
from 862.22M
Increased by 11.51%
EPS This Year
-1.63
from -3.43
EPS Next Year
-1.11
from -1.63
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 894.9M | 1.1B | 1.2B | 1.3B | 1.5B |
| Avg | 862.2M | 961.4M | 1.1B | 1.2B | 1.3B |
| Low | 783.0M | 885.6M | 945.3M | 1.1B | 1.2B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 19.7% | 23.1% | 25.2% | 25.0% | 23.2% |
| Avg | 15.3% | 11.5% | 10.0% | 11.9% | 11.4% |
| Low | 4.7% | 2.7% | -1.7% | 2.1% | 1.6% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.43 | -0.74 | -0.21 | 0.24 | 0.70 |
| Avg | -1.63 | -1.11 | -0.67 | 0.23 | 0.68 |
| Low | -1.92 | -1.41 | -1.00 | 0.23 | 0.66 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 199.9% |
| Avg | - | - | - | - | 191.3% |
| Low | - | - | - | - | 179.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.